Clinical Trial Update: First Line TIP in Poor Prognosis TGCTs. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating first-line TIP regimen in poor prognosis germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Snippet

Sponsor: National Cancer Institute, Slovakia | Conditions: Germ Cell Tumor | Phase 2 | Status: COMPLETED